MedTrace Logo

Intrathecal Stem Cells in Brain Injury

NCT01019733 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2011-01-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether the plasticity of autologous intrathecal hematopoietic cells would improve the neurologic evolution of the pediatric patients with hypoxic/ischemic brain injury.

Conditions

  • Hypoxia-Ischemia, Cerebral
  • Cerebral Palsy

Interventions

PROCEDURE

Intrathecal Autologous Stem Cells

Patients will be stimulated with Granulocyte Colony Stimulating Factor (G-CSF) 5 times, harvest bone marrow and infused 8 to 10 mL of stem cells (CD34+) by intrathecal via.

Sponsors & Collaborators

  • Hospital Universitario Dr. Jose E. Gonzalez

    lead OTHER

Principal Investigators

  • Maria C Mancias-Guerra, MD · Hospital Universitario Dr. Jose E. Gonzalez

  • Arturo Garza-Alatorre, MD · Hospital Universitario Dr. Jose E. Gonzalez

  • Laura N Rodriguez-Romo, MD · Hospital Universitario Dr. Jose E. Gonzalez

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-04-30
Completion
2011-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01019733 on ClinicalTrials.gov